GPO Plus Inc (OTCMKTS:GPOX) Reaches Agreement to Acquire Nutriumph® Supplements and HERBERALL®
Publicly traded company of diversified Group Purchasing Organisations, GPO Plus Inc (OTCMKTS:GPOX), on June 6, 2022, announced signing a binding letter of intent for the acquisition of Nutriumph Supplements including the flagship product Herberall from Orev, a Nevada limited liability company. This is expected to close by June 30, 2022.
Market Stats
On Monday, GPOX stock ended flat at $0.28 with 125 shares, compared to its average volume of 13K shares. The stock moved within a range of $0.2800 – 0.2800 after opening trading at $0.28.
GPOPlus+ Enters Agreement to Acquire Nutriumph® Supplements and HERBERALL®
Acquisitions of HERBERALL and Nutriumph are the first set of acquisitions by GPOX since it announced its acquisitive growth strategy. Through this, GPOX has forayed into the high-growth sector of supplements, vitamins as well as nutraceuticals, leading to strategic expansion.
The Nutriumph product line would be a part of the portfolio of consumer-packaged goods for the Phase 1 launch of Distro+, GPOX’s distribution wing. An innovative supplement firm, Nutriumph provides premium nutraceuticals for assisting consumers to reach wellness and health goals.
Made with natural and finest quality ingredients, Nutriumph’s products come with strict key certifications. These include Gluten-Free, 100% Vegan, Sugar-Free, Non-GMO, and USDA Certified Organic. The products are Made in the USA at facilities approved by FDA and following Good Manufacturing Practices.
The top-selling product HERBERALL is a powerful and 100% natural dietary Brain support supplement blend promoting mental awareness and alertness. It is designed as an alternative to harmful and addiction-forming medications. HERBERALL also improves mental focus and energy.
Key Quote
Nadege Bellissan, CEO of Nutriumph®, said “GPOX and Nutriumph® is a match made in heaven!” Bellissan continued, “GPOX has significant experience in the health and wellness field which makes for the perfect partner for Nutriumph® to strengthen its position in the nutraceutical market. I’m confident that by joining forces and resources we will grow to see new heights.”
Traders Corner
GPOX stock is trading below the 20-Day and 50-Day Moving averages of $0.27 and $0.54 respectively. Moreover, the stock is trading below the 200-Day moving average of $1.54.
